Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized split-face trial of microneedling with topical fluorouracil for facial actinic keratosis
RBR-2bqy9pPhase 3Completed
- Sponsor
- Universidade Federal do Rio Grande do Sul
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of fluorouracil in actinic keratosis (AK) (2 arms), sponsored by Universidade Federal do Rio Grande do Sul. Started Mar 2016; status: completed.
02
Drugs
fluorouracil
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on RBR-2bqy9p.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2bqy9p.